Evanson Jeff

EDGAR CIK 0001760511

Outlook Therapeutics, Inc. - OTLK

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
CHIEF COMMERCIAL OFFICER
Direct Buys
1
$26,243
62,484 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/07/2024
03/11/2024
Buy
62,484 @ $0.42
 $26,243 808,459 (8.38%) Direct